Drug and gene therapy offer hope for CF sufferers

The Government has been urged to assess a new drug that treats the underlying cause of cystic fibrosis.

The drug, Orkambi, has already been approved by medical authorities in the US after it was shown to improve lung function and reduce worsening of the condition by almost 40%.

It has to be approved by the European Medicines Agency and the HSE.